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Abstract Abdominal-pelvic pain is the dominant symptom in endometriosis, one of the most 
common pathologies that affect women, being also a multifactorial disorder. Exploratory 
laparoscopy allows the correct assessment of the location as well as severity and extent 
of the lesions, thus representing the current gold standard in diagnosis. The correlation 
of pain intensity with the evolutionary stage of endometriosis is inconstant. Surgical 
treatment, preferably performed laparoscopically, includes the excision of the ectopic 
endometrium, having as a primary objective the control of persistent pain and the 
removal of all endometriotic foci. This procedure helps to improve the life quality of the 
patient, to reduce relapses, to control postoperative pain, and to eliminate the disease. 
Pre- and post-operative adjuvant medical treatment is used due to its effects on the 
symptomatology, prolonging the asymptomatic period of the disease. Despite the use of 
the above procedures, there are cases in which the abdominal-pelvic pain persists even 
after surgery, which makes endometriosis a significant challenge for both the specialist 
and the patient, as well as for the medical system itself, as the study of the pathogenic 
mechanisms is yet the subject of numerous studies. Nutritional education in these 
patients is essential, given the recommendation to restrict the range of foods and to 
increase other foods that have an important role in reducing the risk or even leading to 
regression of the endometrial pathology.   
  












Highlights ✓ Pain is the main symptom in endometriosis and its control/ monitoring by physician and 
patients is essential. 
✓ The standard surgical treatment consists in laparoscopic excision of the ectopic 
endometrium, plus adjuvant pre/ postoperative medical therapy.   
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Introduction 
Endometriosis is one of the most common 
gynecological and surgical pathologies that affect 
women during the fertile period, being a condition 
maintained by the presence of estrogen hormones (1, 2). 
It is the leading cause of chronic pelvic pain in women 
of reproductive age (3). The condition is defined by “the 
presence of endometrial glands and stroma outside the 
endometrium.” Thus, it can frequently affect the pelvic 
organs (the ovaries, Douglas’ cul-de-sac, the fallopian 
tubes and the uterine ligaments) and, more rarely, the 
structures in the peritoneal cavity, the periumbilical 
tissues, and even structures located far from the internal 
genitalia (the lymph nodes, the lungs, the heart, the 
bones) (4).  
Discussions 
Etiopathogenesis 
Endometriosis is a multifactorial disorder. Data in 
the literature show an increased frequency of this 
pathology in women aged 20-50 years, this being based 
on the estrogen involvement in the pathogenesis of the 
disease (5). Genetic factors play an important role in the 
occurrence of endometriosis, patients with a 1st degree 
affected relative having a risk of developing 
endometriosis of approximately 7 to 10 times higher 
than other women, with multiple identified loci: WNT4, 
CDKN2B-AS1 and GREB1 [5]. 
Endometriosis presents a significant challenge to 
the medical system since its actual prevalence is difficult 
to estimate due to several factors: the diagnosis of 
certainty is made laparoscopically, many women being 
asymptomatic, and many of those who experience 
symptoms do not consult a doctor for a correct diagnosis 
(6). However, studies published in specialized journals 
reveal a prevalence of endometriosis of approximately 
50% among women with chronic pelvic pain at a fertile 
age (7). 
Among the risk factors are nulliparity, early 
menarche, and frequent or prolonged menstruation (3). 
Lifestyle, but especially dietary habits, appear to play an 
essential role in the establishment of endometriosis and 
frequently consumed foods such as red meat, coffee, and 
trans fats are also considered risk factors. As for 
protective factors, we note pregnancy, menopause, 
breastfeeding, and consumption of fresh vegetables, 
fruits, and omega -3 polyunsaturated fatty acids (3, 8). 
 Pain in Endometriosis 
The clinical manifestations of endometriosis 
depend on the location of the lesions, the most common 
being abdominal-pelvic pain, dyspareunia, and 
dysmenorrhea (9). Women who experience symptoms 
of endometriosis have a low quality of life, as reported 
in medical studies (10). Moreover, the data in the 
literature reveal that the partners of the women affected 
by endometriosis are also affected, this being a disorder 
that compromises other aspects of the couple’s life 
(intimacy, pregnancy planning, active life, household 
income, etc.) (11).  
Mechanism of pain in endometriosis 
Pain in endometriosis occurs due to the long-term 
stimulation of nociceptive receptors, but, despite this, 
the precise mechanisms which lead to the occurrence of 
pain are incompletely elucidated, with several theories 
postulated (12). One posits that endometriosis occurs 
due to the direct and indirect effect of active bleeding of 
the endometrial tissue with abnormal localization (9). 
Another theory posits an inflammatory cause in which 
cytokines and growth factors which activate the 
macrophages and other cells associated with the 
functional endometrial tissue are suspected (9, 13). A 
third postulation which has gained increasing numbers 
of followers assumes that pain in endometriosis occurs 
through the irritation or direct invasion of the nerves by 
the ectopic endometrial tissue (especially those within 
Douglas’ cul-de-sac) (9). However, all three theories 
may play some role in understanding the 
etiopathogenesis of pain in endometriosis (9).  
Measurement of pain 
Since pain is the primary symptom in 
endometriosis, its quantification in time has been 
attempted by the introduction of different systems such 
as a Visual Analogue Scale (VAS), the McGill Pain 
Questionnaire, or a unique, simple categorical scale. 
Despite these efforts, studies have generally shown that 
the intensity of pain is not correlated with the severity of 
the disease (9, 14). 
The psychological impact of pain in endometriosis  
 A study conducted on 81 women with chronic 
pelvic pain has shown that women with endometriosis 
have a psychological profile different from those with 
pelvic pain due to other causes. Also, pain intensity is 
not always correlated with standardized psychometric 
scores, thus concluding that there are various 
psychological aspects which predispose confident 




The specialist can diagnose endometriosis after a 
case history and clinical examination in approximately 
80% of the cases. Being an estrogen-dependent 
Abdominal-pelvic pain in women with endometriosis 
160 
affliction, endometriosis is most commonly suspected in 
women at a reproductive age who suffer from chronic 
abdominal-pelvic pain. The clinical examination must 
include a speculum and a bimanual examination for 
more accurate diagnosis (16). 
Invasive paraclinical diagnosis 
The gold standard in the diagnosis of endometriosis 
remains (exploratory and perhaps therapeutic) 
laparoscopy followed by the withdrawal of bioptic 
samples for making the diagnosis of certainty; the open 
path approach is reserved for cases in which laparoscopy 
is contraindicated (1, 16, 17).  
Data that permit the determination of the stage of 
endometriosis can also be obtained laparoscopically. 
Several stage scales have been used in time, one of the 
most important being American Fertility Society 
classification of endometriosis (18, 19). A retrospective 
study conducted at Tohoku University Hospital on 618 
patients diagnosed with endometriosis following 
laparoscopic exploration revealed that in 40% of the 
cases, the stage of endometriosis was not correlated with 
the severity of the pelvic pain experienced by those 
patients. At laparoscopic exploration, there have been 
women with advanced stages of the disease who did not 
experience severe abdominal-pelvic pain and women 
with mild stages of the disease whose quality of life was 
low due to severe pelvic pain (20). 
Non-invasive paraclinical diagnosis  
Although laparoscopy is the gold standard for the 
diagnosis of endometriosis, its disadvantages 
(invasiveness, delay in diagnosis and treatment, major 
limitation in the diagnosis of retroperitoneal lesions) 
have led, in recent years, to intensive research to find 
more efficient and less invasive methods for diagnosing 
this extremely unpleasant and persistent-pain causing 
malady (20).  
Despite such efforts, imaging explorations 
(abdominal-pelvic ultrasound, MRI, CT with contrast 
medium) and the identification of serum markers for 
endometriosis (CA-125, CA 19-9, CA-125+NLR, CA-
125+MCP-1+leptin, CA-125+MCP-1+leptin+MIF) 
have limited utility in medical practice, the role of 
laparoscopy continuing to be of a crucial importance 
(16, 21). 
Treatment 
The treatment of endometriosis can be surgical, 
medical, or combined (22). The objectives of the 
treatment are the control of the symptoms and the 
decrease in the relapse rate, as there is no curative 
treatment. The choice of optimal treatment for the 
patients should consider the particularities of each case 
since currently no evidence support one therapeutic 
method over another regarding the control of the 
symptoms (3). However, irrespective of the method of 
treatment chosen, the effect of treatment in 
endometriosis is generally accepted as being useful 
regarding rates of recurrence and control of the 
symptoms (3). 
Surgical treatment includes the ablation or the 
excision of the ectopic endometrium and can be 
performed laparoscopically (preferably) or classically. 
The goal of the surgical treatment is the removal of all 
foci of endometriosis identified in the pelvic genital 
structures and within the peritoneal cavity, a procedure 
which has been identified as significantly relieving the 
painful symptoms, improving the quality of the patients’ 
life, and reducing the risk of relapse (17).  
Control of postoperative pain 
The rates of postoperative recurrence for pelvic 
pain, in the case of patients with endometriosis, are still 
significant (23). This significant rate of recurrence is 
associated with ovulation, and thus it has been found 
that the inhibition of ovulation after surgery greatly 
decreases the risk of postoperative relapse (24). 
Therefore, pre- and postoperative adjuvant medical 
treatment is used due to its effects on symptomatology, 
prolonging the asymptomatic or oligosymptomatic 
period of the patients (1). In the immediate postoperative 
period, the administration of painkillers and anti-
inflammatory treatment is sufficient (25). 
Subsequently, attention is directed to the prevention 
of postoperative recurrences. For this purpose, several 
classes of medication are used in different therapeutic 
regimens. The theory “the production of pseudo-
pregnancy,” considered to be the gold standard in the 
past, consists of inducing pseudo-pregnancy in patients 
with endometriosis by the administration of gestagenic 
agents followed by the administration of GnRH and 
Danazol analogues. Currently, this strategy has been 
replaced by simple (Dienogest) progesterone treatment 
or the treatment with GnRH analogues, these having the 
same efficacy as the old therapeutic strategy, as 
evidenced by numerous studies (9, 26). 
Treatment with GnRH analogues (Nafarelin 
acetate, Goserelin acetate) has proven effective in the 
control of painful symptom recurrence in the 
postoperative period, but it also has adverse effects such 
as bone demineralisation, vasomotor symptoms, and 
mood swings. Therefore, it is recommended that the 
value of serum estradiol be maintained, as much as 
possible, around 60 pg/mL (26). 
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Danazol, a derivative of 17 α-ethinyltestosteron, has 
proven as efficient as GnRH analogues in the control of 
postoperative pain. On the other hand, GnRH analogues 
have been better tolerated, since Danazol has more 
frequent and important adverse reactions:  hirsutism, 
acne, weight gain, and deepening of the voice (10). 
As for the control of postoperative pain through the 
administration of oral contraceptives, results are mixed 
regarding the efficacy of continuous vs. cyclic regimens, 
leaving the preferred method to be confirmed by future 
studies (9).   
Another approach worth consideration is the 
determination of nutrient deficiencies in patients, 
knowing that such deficiencies alter lipid metabolism, 
cause oxidative stress, and strongly promote epigenetic 
changes involved in the genesis and progression of this 
pathology. The nutritional recommendations in patients 
with endometrial pathology specifically target the 
consumption of fresh vegetables and fruits, of organic 
origin, of products rich in omega-3 fatty acids, and of 
whole grains that have proven their protective effect. 
Along with these recommendations, administering 
resveratrol supplements, dietary supplementation with 
vitamin D, and N-acetylcysteine seem to have an 
adjuvant effect (27-29). 
Conclusions 
Pain is the main symptom in endometriosis and its 
control through different methods is a significant 
challenge for both the physician and the patient. Since 
no curative treatment is available due to the non-
clarification of pathogenic mechanisms, the 
management of endometriosis is based on the control of 
the symptomatology and prevention of relapse, for such 
purposes being used both medical and surgical methods. 
The standard surgical treatment consists in excision or 
ablation of the ectopic endometrium through a 
laparoscopic approach, and the pre- and postoperative 
medical treatment is an adjuvant one (NSAIDs, oral 
contraceptives, GnRH analogue, Danazol).  
Despite these therapeutic measures, there is a fairly 
high rate of relapse and implicitly of the quasi-constant 
pain that accompanies it. Nutritional education in these 
patients is important, given the recommendation to 
restrict certain foods and increase intake of foods that 
reduce the risk of or even lead to regression of the 
endometrial pathology. It is necessary to reconsider 
nutritional medical intervention as well as dietetic 
education in these patients, these two aspects being 
important tools in the prevention and treatment of 
endometriosis. 
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